MAP Pharmaceuticals, Inc.·4

Feb 14, 5:42 PM ET

ARMER THOMAS A 4

4 · MAP Pharmaceuticals, Inc. · Filed Feb 14, 2012

Insider Transaction Report

Form 4
Period: 2012-02-13
ARMER THOMAS A
DirectorCSO, Director
Transactions
  • Sale

    Common Stock

    2012-02-13$16.00/sh2,800$44,800180,161 total
  • Sale

    Common Stock

    2012-02-14$15.62/sh30,999$484,142149,162 total
Footnotes (2)
  • [F1]The transaction was made pursuant to 10b5-1 trading plan in effect at the time of the transactions.
  • [F2]The range of price is from $15.175 to $15.78 per share. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, or a secuirty holder of the issuer.

Documents

1 file
  • 4
    rrd334330.xmlPrimary

    FORM 4